Market Currents
More on Novartis (NVS) Q4: Adjusted profit +3% to $3.1B. Net profit +74% to $2.05B, below...
-
Wednesday, January 23, 4:04 AM ETMore on Novartis (NVS) Q4: Adjusted profit +3% to $3.1B. Net profit +74% to $2.05B, below consensus of $2.38B. Last year was affected by writedowns. Pharmaceutical division sales flat at $8.3B, Diovan sales -25% to $992M after loss of patent protection. Shares +2.4% in Zurich.
Other date
Latest Earnings Articles
